OMNI Health, Inc. (OMHE) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
P/E 0.04 means the share price is 0.04 times one year of earnings per share.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerOMNI Health, Inc. (OMHE) trades at $0.00005. Omni Health, Inc., through its subsidiary Malecon Pharmacy, Inc., operates a pharmacy in Hialeah, Florida, providing health, wellness, and pharmaceutical services. Sector: Healthcare.
Price as of · Last analyzed: Jun 15, 2026Analyst Coverage for OMHE: OMHE does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
OMNI Health, Inc. (OMHE) Healthcare & Pipeline Overview
Omni Health, Inc., through its subsidiary Malecon Pharmacy, Inc., operates a community pharmacy in Hialeah, Florida, delivering health, wellness, and traditional pharmaceutical services. The company also manufactures, sells, and distributes its proprietary anti-aging cream, positioning itself at the intersection of local healthcare provision and the specialized cosmetic market as a subsidiary of LX Retail Group, Inc.
What Is the Investment Thesis for OMHE?
Omni Health, Inc. presents a unique operational profile, combining local pharmacy services with a proprietary anti-aging cream product line. The company demonstrates strong profitability metrics, with a reported Profit Margin of 27.0% and a Gross Margin of 33.1%, indicating efficient cost management relative to its revenue. Its P/E ratio of 0.04 suggests a potentially undervalued asset, though this must be considered in the context of its small market capitalization of $0.00B and OTC trading status. Key value drivers include the stable demand for community pharmacy services in Hialeah and the potential for growth within the anti-aging cosmetics market. Growth catalysts could involve expanding the distribution channels for its anti-aging cream, enhancing the range of health and wellness services offered at Malecon Pharmacy, or leveraging its subsidiary relationship with LX Retail Group, Inc. for broader market reach or operational efficiencies. However, the company faces risks associated with its limited geographic footprint, intense competition in both pharmacy and cosmetics, and the inherent challenges of operating on the OTC market, including potential liquidity issues and reduced transparency.
Based on FMP financials and quantitative analysis
OMHE Key Highlights
Omni Health, Inc. maintains a robust Profit Margin of 27.0%, indicating strong operational efficiency and profitability from its combined pharmacy and anti-aging cream businesses.
- The company reports a Gross Margin of 33.1%, reflecting a healthy spread between its revenue and the cost of goods sold for its services and products.
- With a P/E ratio of 0.04, Omni Health, Inc. trades at a significantly low multiple relative to its earnings, which could suggest a deep value proposition or reflect market perceptions of its small market capitalization and OTC status.
- Omni Health, Inc. operates with a market capitalization of $0.00B, positioning it as a micro-cap entity within the healthcare sector.
- The company does not currently offer a dividend yield, indicating a strategy focused on reinvesting earnings into the business rather than distributing profits to shareholders.
Who Are OMHE's Competitors?
OMHE is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| LGND Ligand Pharmaceuticals Incorporated | $302.96 | +0.07% | $6.07B | 96 5-pillar |
| MEDS TRxADE HEALTH, Inc. | $3.68 | -9.36% | $9.65M | — |
| MSLE Satellos Bioscience Inc. Common Stock | $8.50 | -0.12% | $11.0M | — |
| NEUP Neuphoria Therapeutics Inc. | $3.47 | -1.14% | $18.8M | — |
| AIXC AIxCrypto Holdings, Inc. | $1.01 | -39.16% | $20.4M | — |
| RNTX Rein Therapeutics, Inc. | $0.80 | -6.03% | $22.4M | — |
| KYNB Kyntra Bio, Inc. | $6.31 | -2.92% | $25.5M | — |
| YI 111, Inc. | $3.22 | -2.57% | $28.1M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are OMHE's Key Strengths?
Strong profitability metrics with a 27.0% Profit Margin and 33.1% Gross Margin.
- Dual business model combining stable local pharmacy services with a niche anti-aging cream product.
- Established physical presence in Hialeah, Florida, fostering community trust and recurring customer base.
- Proprietary anti-aging cream manufacturing capability offers product control and potential for brand building.
What Are OMHE's Weaknesses?
Extremely small market capitalization of $0.00B, indicating limited scale and potential for capital constraints.
- Limited geographic footprint, relying primarily on a single pharmacy location in Hialeah, Florida.
- Trades on the OTC market ('OTC Other' tier), which typically implies lower liquidity and transparency.
- Reliance on the success of a single proprietary cosmetic product in a highly competitive market.
What Are the Key Risks for OMHE?
Financial-distress signal — its Altman Z-Score of 0.50 sits in the distress zone (elevated bankruptcy risk).
- Intense competition from larger national pharmacy chains and well-established cosmetic brands could limit market share and pricing power.
- Adverse regulatory changes in the healthcare or cosmetic industries could impact operational compliance and product viability.
- Economic downturns or local economic shifts in Hialeah could reduce discretionary spending on wellness services and anti-aging products.
- Limited geographic footprint and reliance on a single pharmacy location make the company vulnerable to local market dynamics and competition.
- Challenges associated with trading on the 'OTC Other' market, including low liquidity, limited transparency, and potential for price volatility.
What Are OMHE's Competitive Advantages?
- Established local presence and community trust through Malecon Pharmacy, Inc. in Hialeah, Florida.
- Integrated business model offering both essential pharmacy services and a proprietary cosmetic product.
- Manufacturing capability for its specific anti-aging cream, providing product control and potential for differentiation.
- Subsidiary relationship with LX Retail Group, Inc., potentially offering corporate backing and operational synergies.
What Does OMHE Do?
Omni Health, Inc. operates primarily through its wholly-owned subsidiary, Malecon Pharmacy, Inc., establishing a foundational presence in the local healthcare landscape of Hialeah, Florida. The company's core business revolves around providing essential health, wellness, and comprehensive pharmacy services to the community. This includes dispensing prescription medications, offering over-the-counter products, and potentially providing various health consultations and preventative care services typical of a community pharmacy. Beyond traditional pharmacy operations, Omni Health, Inc. has diversified its offerings by engaging in the manufacturing, selling, and distribution of its own proprietary anti-aging cream. This dual business model positions the company within both the medical-pharmaceutical sector and the specialized cosmetic market, aiming to cater to a broader range of consumer health and wellness needs. Headquartered in Hialeah, Florida, Omni Health, Inc. functions as a subsidiary of LX Retail Group, Inc., which may provide strategic support or synergistic opportunities within a larger corporate structure. The company's operational focus is rooted in serving its local Hialeah market, leveraging its physical pharmacy location to build community trust and customer loyalty while simultaneously pursuing growth in the niche anti-aging product segment.
What Products and Services Does OMHE Offer?
- Operates Malecon Pharmacy, Inc., a community pharmacy located in Hialeah, Florida.
- Provides a range of health services to its local clientele.
- Offers various wellness services, catering to holistic health needs.
- Dispenses prescription medications and sells over-the-counter pharmaceutical products.
- Manufactures its own proprietary anti-aging cream.
- Sells the anti-aging cream directly and through its distribution channels.
- Distributes the anti-aging cream to consumers.
- Functions as a subsidiary entity under the corporate umbrella of LX Retail Group, Inc.
How Does OMHE Make Money?
- Generates revenue from the sale of prescription medications and over-the-counter health products through Malecon Pharmacy, Inc.
- Earns income by providing various health and wellness services to the community.
- Derives revenue from the manufacturing, direct sales, and distribution of its proprietary anti-aging cream.
- Operates as a local, community-focused service provider complemented by a specialized product line.
What Industry Does OMHE Operate In?
Omni Health, Inc. operates within the diverse healthcare sector, specifically positioned in the medical-pharmaceutical industry through its Malecon Pharmacy subsidiary, while also tapping into the broader wellness and cosmetics market with its anti-aging cream. The community pharmacy segment is characterized by localized competition from both independent pharmacies and large national chains, with a growing trend towards offering expanded health and wellness services beyond traditional prescription dispensing. The anti-aging market, on the other hand, is a global, multi-billion dollar industry driven by consumer demand for youth-preserving products, facing intense competition from established beauty brands and emerging direct-to-consumer players. Omni Health's strategy of combining these two distinct areas allows it to serve a local, recurring customer base for pharmacy needs while also pursuing growth in a higher-margin, specialized product category. Its small scale and local focus differentiate it from larger pharmaceutical companies, placing it in a niche where personalized service and product specialization are key competitive factors.
Who Are OMHE's Key Customers?
- Residents of Hialeah, Florida, seeking prescription fulfillment and general pharmacy services.
- Individuals within the local community interested in health and wellness consultations or products.
- Consumers seeking specialized anti-aging cosmetic products.
- Patients requiring accessible and personalized local healthcare support.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Key Financial Metrics
Return on equity for OMNI Health, Inc. stands at 73.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 22.9%, showing how much profit it generates from its asset base. OMHE trades at a trailing price-to-earnings ratio of 0.04, below the Healthcare sector average of ~21.10x. A current ratio of 1.25 indicates the company holds enough short-term assets to cover its near-term obligations.
Company Profile
OMNI Health, Inc. operates in the Medical - Pharmaceuticals industry within the Healthcare sector. It is headquartered in Hialeah, US. The company is led by CEO Andrey Soloviev. OMHE has traded publicly since 2015.
Financial Health
OMNI Health, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 0.50 places it in the distress zone, a signal of elevated financial risk.
OMHE Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
OMHE Latest News
-
Stocks That Hit 52-Week Lows On Tuesday
· Mar 24, 2020
OMHE Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for OMHE.
Price Targets
Wall Street price target analysis for OMHE.
OMHE MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for OMHE; grades run from A+ (80-100) to F (below 30).
Leadership: Andrey Soloviev
CEO
His professional credentials and detailed experience prior to his role at Omni Health, Inc.
Track Record: Specific achievements, strategic decisions, or company milestones directly attributable to Andrey Soloviev's leadership at Omni Health, Inc. are not detailed in the provided information. His track record in this role is currently unknown.
OMHE OTC Market Information
Omni Health, Inc. trades on the OTC market under the 'OTC Other' tier, which represents the lowest tier of OTC Markets. Unlike companies listed on major exchanges like NYSE or NASDAQ, 'OTC Other' companies have minimal to no disclosure requirements. This tier is typically for companies that do not meet the standards for OTCQX or OTCQB, or choose not to provide financial information. This classification signifies a significantly lower level of regulatory oversight and public disclosure compared to exchange-listed securities, which adhere to stringent SEC reporting standards.
- OTC Tier: OTC Other
- Lack of transparency and limited public disclosure, making it difficult to assess the company's financial health and operations.
- Extremely low trading liquidity, leading to wide bid-ask spreads and potential difficulty in buying or selling shares.
- Increased susceptibility to price manipulation due to low trading volume and minimal regulatory oversight.
- Limited or no analyst coverage, resulting in a lack of independent research and valuation insights.
- Higher volatility and greater risk of significant capital loss compared to exchange-listed securities.
- Verify any available financial statements and audit reports, scrutinizing revenue recognition and expense reporting.
- Research the background and track record of management and key executives beyond what is publicly stated.
- Thoroughly understand the company's business model, revenue streams, and competitive landscape.
- Investigate any regulatory filings or news releases, however sparse, for material events or changes.
- Assess the company's share structure, outstanding shares, and any potential dilution risks.
- Evaluate the legitimacy and operational status of Malecon Pharmacy, Inc. and its anti-aging cream business.
- Consider the implications of its subsidiary relationship with LX Retail Group, Inc. and any potential support or risks.
- Operates a tangible business through Malecon Pharmacy, Inc. in Hialeah, Florida, providing local services.
- Engages in the manufacturing, selling, and distribution of a specific product, an anti-aging cream.
- Identified as a subsidiary of LX Retail Group, Inc., suggesting a corporate parentage.
- Headquartered in a specific, verifiable location in Hialeah, Florida.
OMNI Health, Inc. Healthcare Stock: Key Questions Answered
What are the implications of Omni Health, Inc. trading on the OTC market?
Trading on the OTC market, specifically in the 'OTC Other' tier, carries several significant implications for Omni Health, Inc. and its investors.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- The dossier is based solely on the provided source data, which is limited in scope, particularly regarding historical context, detailed operational specifics, and financial breakdowns beyond key metrics.
- Information regarding CEO background and track record is explicitly stated as 'Unknown' due to lack of source data.
- Growth opportunities and risks are inferred from the company's stated business activities and general industry knowledge, adhering strictly to non-speculative language.
- The low market capitalization of $0.00B is noted as provided, and its implications are discussed in the context of OTC trading.